FDA weighs black box warning for COVID-19 vaccines
Digest more
More changes are coming from the Food and Drug Administration as officials move to get rid of warning labels on some ...
MedPage Today on MSN
Expand labeling for testosterone replacement therapy, FDA panel says
Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its ...
Health care professionals can have a powerful impact on labeling requirements for drugs by formally petitioning the FDA for ...
An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.
The agency’s proposed rule would require the display of a compact informational box containing certain nutrient information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback